Extendicare Inc faces a challenging trading day as its stock price declines.
Extendicare Inc (EXE.TO) is experiencing a downturn, with its stock sliding by 2.61% in today's trading session. This decline comes despite the company's recent performance announcements, raising concerns among investors about its future prospects.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Extendicare Inc
EXE.TO
EXE.TO
Extendicare Inc
WealthAwesomeMarket cap
$3.48B
P/E
25.4x
Div. yield
1.43%
Div. / share
$0.51
52W high
$39.09
52W low
$12.09
1W change
-4.88%
Beta
1.16
Analyst Price Targets
Based on analyst covering EXE
Wall Street analysts forecast EXE stock price to rise 11.2% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$38.83
+11.2% Upside
Current Price
C$34.91
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EXE's historical volatility
30-Day Vol
30.0%
Annualized
90-Day Vol
34.3%
Annualized
Trend (90d)
+18.1%
Annualized drift
90d Mean
C$37.24
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$35.67 | C$32.16 – C$39.56 |
| 60 trading days | C$36.44 | C$31.48 – C$42.20 |
| 90 trading days | C$37.24 | C$31.12 – C$44.56 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious as Extendicare's stock faces downward pressure, reflecting potential uncertainties in its operational performance.
Market Cap: CA$3.48 billion
Despite a solid market cap, the stock's recent performance raises questions about investor confidence.
Bull case
Extendicare has shown growth in adjusted EBITDA in previous quarters, indicating a strong operational foundation that could support a rebound.
Bear case
The current slide may suggest deeper issues within the company or negative market sentiment, which could lead to further declines if not addressed.
Market Reaction
Advertisement
Today, Extendicare's stock fell to CA$34.00, a decline of 2.61%. This drop comes as investors digest the company's recent financial results and broader market conditions, which may be influencing sentiment negatively.
Recent Performance Overview
Despite a reported increase in adjusted EBITDA in past quarters, today's decline raises questions about the sustainability of this growth. Investors may need to reassess their outlook on Extendicare, especially in light of the current market dynamics.
Future Outlook
As Extendicare navigates this downturn, stakeholders should keep an eye on upcoming earnings reports and any strategic announcements that could impact its recovery. The company has shown resilience in the past, but today's performance serves as a reminder of the volatility in the healthcare sector.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
